Patents Assigned to Afecta Pharmaceuticals
  • Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones
    Patent number: 6897212
    Abstract: A method for treating the psychiatric disorders known as oppositional defiant disorder and conduct disorder is disclosed. The method comprises the administration of a compound according to Formula I or II to a patient suffering from oppositional defiant disorder and/or conduct disorder. The compound may be either a racemic mixture or e.g. the levorotatory form. It may be short acting or in a sustained release, long acting form. Molindone or a pharmaceutically acceptable salt of molindone is a preferred embodiment.
    Type: Grant
    Filed: May 7, 2003
    Date of Patent: May 24, 2005
    Assignee: Afecta Pharmaceuticals
    Inventors: David E. Comings, Bruce Kovacs, Jim MacMurry